Benzydamine, cetylpyridinium (* Andolex-c Raspberry, Andolex-c, Andolex-c Strawberry, Oroflam, Andolex-c Honey/lemon, Andolex-c Orange, Andolex)
Benzydamine, cetylpyridinium
Inova Pharmaceuticals (Pty) Ltd
Registration
- Applicant
- Inova Pharmaceuticals (Pty) Ltd
- Registrations
- 7
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| * andolex-c lozenges raspberry EACH LOZENGE CONTAINS: BENZYDAMINE HYDROCHLORIDE 3,00 mg, CETYLPYRIDINIUM CHLORIDE 1,33 mg | Lozenges | 31004231/16.4/0042 | Registered | Not determined | None |
| Andolex-c oral gel EACH 10,0 g GEL CONTAINS BENZYDAMINE HYDROCHLORIDE 0,1 g CETYLPYRIDINIUM CHLORIDE 0,01 g | Oral gel | 33028533/16.4/0285 | Registered | Not determined | None |
| Andolex-c lozenges strawberry EACH LOZENGE CONTAINS BENZYDAMINE HYDROCHLORIDE 3,0 mg CETYLPYRIDINIUM CHLORIDE 1,33 mg | Lozenges | 33037433/16.4/0374 | Registered | Not determined | None |
| Oroflam lozenges EACH LOZENGE CONTAINS BENZYDAMINE HYDROCHLORIDE 3,0 mg CETYLPYRIDINIUM CHLORIDE 1,33 mg | 3.00 mgLozenges | 34044534/16.4/0445Approved 5 January 2021 | Registered | Not determined | PIPIL |
| Andolex-c lozenges honey/lemon EACH LOZENGE CONTAINS BENZYDAMINE HYDROCHLORIDE 3,0 mg CETYLPYRIDINIUM CHLORIDE 1,33 mg | Lozenges | 35032035/16.4/0320 | Registered | Not determined | None |
| Andolex-c lozenges orange EACH LOZENGE CONTAINS BENZYDAMINE HYDROCHLORIDE 3,0 mg CETYLPYRIDINIUM CHLORIDE 1,33 mg | Lozenges | 36019536/16.4/0195 | Registered | Not determined | None |
| Andolex 0,15/0,05 EACH 1,0 ml LIQUID CONTAINS BENZYDAMINE HYDROCHLORIDE 1,5 mg CETYLPYRIDINIUM CHLORIDE 1,34 mg | 0,15/0,05Liquid | 55028655/16.4/0286Approved 30 August 2022 | Registered | Not determined | PIPIL |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.